These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 21128840

  • 1. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A, Saigi I, García-Patterson A, Santos MD, Adelantado JM, Ginovart G, de Leiva A, Corcoy R.
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [Abstract] [Full Text] [Related]

  • 2. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
    Gong Y, Wei T, Liu Y, Wang J, Yan J, Yang D, Luo S, Weng J, Zheng X.
    J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
    [Abstract] [Full Text] [Related]

  • 3. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
    Żurawska-Kliś M, Kosiński M, Kuchnicka A, Rurka M, Hałucha J, Wójcik M, Cypryk K.
    Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
    [Abstract] [Full Text] [Related]

  • 4. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
    Cyganek K, Hebda-Szydlo A, Katra B, Skupien J, Klupa T, Janas I, Kaim I, Sieradzki J, Reron A, Malecki MT.
    Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
    [Abstract] [Full Text] [Related]

  • 5. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Hauffe F, Schaefer-Graf UM, Fauzan R, Schohe AL, Scholle D, Sedlacek L, Scherer KA, Klapp C, Ramsauer B, Henrich W, Schlembach D, Abou-Dakn M.
    Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
    [Abstract] [Full Text] [Related]

  • 6. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P, Juuti M, Walle T, Laatikainen T.
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [Abstract] [Full Text] [Related]

  • 7. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK, Suen M, Pease A, Boyle JA, Soldatos G, Regan J, Wallace EM, Teede HJ.
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [Abstract] [Full Text] [Related]

  • 8. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D, Tuffnell DJ, West J, West HM.
    Cochrane Database Syst Rev; 2016 Jun 07; 2016(6):CD005542. PubMed ID: 27272351
    [Abstract] [Full Text] [Related]

  • 9. Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis.
    González Blanco C, Chico Ballesteros A, Gich Saladich I, Corcoy Pla R.
    Diabetes Technol Ther; 2011 Sep 07; 13(9):907-11. PubMed ID: 21714679
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA, Saboo BD, Joshi SR, Padhiyar JN, Chandarana HK, Shah SJ, Vyas CK, Shah AN.
    Diabetes Metab Syndr; 2013 Sep 07; 7(2):68-71. PubMed ID: 23680243
    [Abstract] [Full Text] [Related]

  • 12. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA, Huang J, DuBord AY, Xu NY, Beestrum M, Niznik C, Yeung AM, Nguyen KT, Klonoff DC, Yee LM.
    J Diabetes Sci Technol; 2023 Sep 07; 17(5):1337-1363. PubMed ID: 37542367
    [Abstract] [Full Text] [Related]

  • 13. Insulin Delivery Method and Admission for Glycemic Control in Pregnant Women with Type 1 Diabetes Mellitus.
    Sperling JD, Maggio L, Has P, Daley J, Coustan DR, Werner EF.
    Am J Perinatol; 2018 Feb 07; 35(3):209-214. PubMed ID: 28709165
    [Abstract] [Full Text] [Related]

  • 14. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.
    Clin Ther; 2008 Aug 07; 30(8):1476-84. PubMed ID: 18803989
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions.
    Chen R, Ben-Haroush A, Weismann-Brenner A, Melamed N, Hod M, Yogev Y.
    Am J Obstet Gynecol; 2007 Oct 07; 197(4):404.e1-5. PubMed ID: 17904979
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.
    Diabetes Care; 2009 Jul 07; 32(7):1170-6. PubMed ID: 19389820
    [Abstract] [Full Text] [Related]

  • 18. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.
    Ogassavara J, Dualib PM, Mattar R, Dib SA, de Almeida-Pititto B.
    Arch Endocrinol Metab; 2023 Jun 19; 67(6):e220483. PubMed ID: 37364140
    [Abstract] [Full Text] [Related]

  • 19. Glycemic control and maternal and fetal outcomes in pregnant women with type 1 diabetes according to the type of basal insulin.
    Chico A, Herranz L, Corcoy R, Ramírez O, Goya MM, Bellart J, González-Romero S, Codina M, Sánchez P, Cortázar A, Acosta D, Picón MJ, Rubio JA, Megía A, Sancho MA, Balsells M, Solá E, González NL, López-López J, GEDE (Group of Diabetes and Pregnancy of the Spanish Diabetes Association).
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov 19; 206():84-91. PubMed ID: 27639606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.